# BSX — Boston Scientific · catalysts, narrative & risks

**Deep-research report — K3vl4r**  
**Symbols:** BSX  
**Sources:** 27  
**Published:** 2026-08-09  
**Canonical:** https://app.k3vl4r.com/research/deep-research-bsx-boston-scientific-catalysts-narrative-risks-1643

---

Below is a synthesis drawn from the new sources [[1]](https://simplywall.st/stocks/us/healthcare/nyse-bsx/boston-scientific)–[[29]](https://seekingalpha.com/symbol/BSX), cross-checked against the internal library [LIB-n] and the first-party company file [DOC-n]. I note where sources disagree or reflect different dates, and I flag the April vs. July guidance cuts, which are commonly conflated.

Note on background: BSX's listing (NYSE) and its classification under *medical_devices* are our own universe inputs, so I am not re-deriving or reporting them as findings here.

## Recent catalysts (roughly late June – late September 2026)

---

_Preview only. The complete multi-source deep-research report — full thesis, evidence, and citations — is available at https://app.k3vl4r.com/research/deep-research-bsx-boston-scientific-catalysts-narrative-risks-1643 (free to sign up)._